𝔖 Bobbio Scriptorium
✦   LIBER   ✦

What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?

✍ Scribed by Christophe Duvoux; Tetsuya Kiuchi; Bernhard Pestalozzi; Ronald Busuttil; Rebecca Miksad


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
198 KB
Volume
17
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Identifying risk for recurrent hepatocel
✍ Edie Y. Chan; Anne M. Larson; Oren K. Fix; Matthew M. Yeh; Adam E. Levy; Ramasam πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 334 KB

The recurrence of hepatocellular carcinoma (HCC) is a major cause of mortality for patients transplanted with HCC. There currently exists no standard method for identifying those patients with a high risk for recurrence. Identification of factors leading to recurrence is necessary to develop an effi

What is the best staging system for hepa
✍ Kim M. Olthoff; Alejandro Forner; Stefan HΓΌbscher; John Fung πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

The purposes of cancer staging are (1) to accurately predict a patient's prognosis and (2) to determine the appropriate interventions. Hepatocellular carcinoma (HCC) is somewhat unique: it usually affects patients with underlying liver disease, and both tumor burden and liver function need to be car

Reply: Role of locoregional therapy for
✍ Paige Porrett; Abraham Shaked; Kim Olthoff πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 34 KB πŸ‘ 1 views

Huo and colleagues 1 appropriately note that the low complete response rate to radiofrequency ablation (RFA) in our study contrasts markedly with much of the published literature. Their surprise regarding this finding originates from the commonly held belief that RFA effectively ablates hepatocellul